Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:06 PM
Ignite Modification Date:
2025-12-24 @ 12:06 PM
NCT ID:
NCT06836661
Eligibility Criteria:
Inclusion Criteria:
\- 1. High-risk primary prevention A. Patients aged more than 40years of any gender without a CVD event (MI, Stroke) with at least two of the following risk factors, A to E with a 10 year documented evidence OF (a to d) a. Diabetes Mellitus b. Hypertension c. Dyslipidaemia d. Microalbuminuria e. Family history of premature CVD event (MI, stroke or CVD-related death under 55 years) B. Patients aged above 50years of any gender without a CVD event (MI, Stroke) with at least one year of documented disease, at least two A to D (Above) 2. High-risk secondary prevention Patients aged above 40 years or above, with a CVD event with any one of the following: options a. MI or stroke less than three months, \<br/\> b. MI or stroke, more than three months, but less than one year with at least one comorbid condition, that is A to E (Above).
c. Patients aged above 60 years or above with MI or stroke greater than three months BUT less than one year, without any comorbid condition. These patients are expected to have a moderate to high risk of a CVD event or death in the next three years.
Exclusion Criteria:
* We will exclude patients with any ONE of the following:
1. Severe cognitive impairment of any aetiology and have no reliable caregivers.
2. Medical conditions with a survival prognosis of less than 12 months.
3. Unable to follow-up for the study period
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
99 Years
Study:
NCT06836661
Study Brief:
Protocol Section:
NCT06836661